mepixanox

Mepixanox is a synthetic small molecule belonging to the xanthone class of compounds. It has been investigated primarily as an analeptic agent, meaning it stimulates the central nervous system and was studied for use in respiratory and cardiorespiratory insufficiency. Some sources also mention potential anxiolytic properties, suggesting possible effects on anxiety via central nervous system modulation. Its mechanism of action is not fully elucidated but is presumed to involve stimulation of the CNS, likely through non-selective mechanisms typical for analeptics. Clinical development reached up to Phase II trials; however, its use has been limited due to adverse effects such as dermatitis[1][2][3][4][5][7].

Other names

pimexone hydrochlorideMepixanoxumMepixanox (INN)3-Methoxy-4-piperidinmethylxanthon